Aleks Engel

Aleks joined Novo Holdings in 2014 and is Partner in the Planetary Health Investments team and is based in Boston.  He was previously part of the Principal Investments team and the Seed Investments team based in Copenhagen.

Prior to joining Novo Holdings, Aleks was employed by Baxter International, Pfizer Global Research and Development, Thomson Scientific & Healthcare, and McKinsey & Company.

Aleks holds a PhD in Biochemical Engineering and a MSc in Chemical Engineering Practice from Massachusetts Institute of Technology (MIT).